Combined tumor‐associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Combined tumor‐associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma

Published:2021-09-20 Issue:5 Volume:39 Page:625-638
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Sun Xiaoqing¹,Wang Caiqin²,Chen Cui³,Huang Jiajia⁴,Wu Xianqiu⁵,Wang Yu⁴^ORCID,He Xiaohua⁴,Cao Jianghua⁴,Jiang Wenqi⁴,Sun Peng⁴,Li Zhiming⁴^ORCID

Affiliation:

1. Department of Intensive Care Unit Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Guangzhou China

2. Department of Medical Oncology Sun Yat‐sen University Sixth Affiliated Hospital Guangzhou China

3. Department of Medical Oncology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China

4. Department of Medical Oncology Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou China

5. Department of Hepatobiliary Surgery Southern Medical University Nanfang Hospital Guangzhou China

Funder

National Natural Science Foundation of China

National Science and Technology Major Project

Guangzhou Science and Technology Program key projects

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2926

Reference33 articles.